FDA Drug Recalls

Recalls / Class II

Class IID-1852-2019

Product

Bacteriostatic Water for Injection, USP, 30 mL vials, Rx only, Mfd. for: Hospira, Inc., Lake Forest, IL 60045 USA. NDC Vial: 0409-3977-01; NDC Carton: 0409-3977-03

Brand name
Bacteriostatic Water
Generic name
Bacteriostatic Water
Active ingredient
Water
Route
Intramuscular, Intravenous, Subcutaneous
NDCs
0409-3977, 0409-1093
FDA application
NDA018802
Affected lot / code info
Lot #: W20308, Exp. Dec 1, 2019

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Pfizer Inc.
Manufacturer
Hospira, Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
235 E 42nd St, New York, New York 10017-5703

Distribution

Quantity
185,700 vials
Distribution pattern
Nationwide US and Puerto Rico

Timeline

Recall initiated
2019-09-06
FDA classified
2019-09-12
Posted by FDA
2019-09-18
Terminated
2023-03-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1852-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Bacteriostatic Water · FDA Drug Recalls